Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026)
Immunocore Holdings (IMCR) posted Exchange Rate Effect of -$6.1 million for Q1 2026, down 322.16% sequentially from -$1.5 million in Q4 2025, and down 172.8% YoY from $8.4 million in Q1 2025.
Immunocore Holdings (IMCR) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported Exchange Rate Effect for 6 years, with the latest figure at -$6.1 million in Q1 2026.
- Quarterly Exchange Rate Effect fell 172.8% year-over-year to -$6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (up 60.93% YoY) and the FY2025 annual result came in at $26.7 million, up 1660.83% from the prior year.
- Exchange Rate Effect fell to -$6.1 million in Q1 2026 per IMCR's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $15.7 million in Q3 2022 and troughed at -$23.3 million in Q4 2022.
- A 5-year average of $1.3 million and a median of $2.2 million in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 215504.37% in 2022, then surged 7564.15% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$23.3 million in 2022, then surged by 146.38% to $10.8 million in 2023, then plunged by 220.86% to -$13.0 million in 2024, then soared by 88.85% to -$1.5 million in 2025, then tumbled by 322.16% to -$6.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$6.1 million, -$1.5 million, and $7.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn | 618,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 618,000.00 |
| Jun 30, 2026 | 618,000.00 |
| Mar 31, 2026 | -6.13 Mn |
| Mar 31, 2026 | -6.13 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Dec 31, 2025 | -1.45 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Sep 30, 2025 | 7.82 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 11.87 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Mar 31, 2025 | 8.43 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Dec 31, 2024 | -13.03 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | -159,000.00 |
| Jun 30, 2024 | -159,000.00 |
| Mar 31, 2024 | -800,000.00 |
| Mar 31, 2024 | -800,000.00 |